Back to top

$SOPH stock is up 7% today. Here's what we see in our data.

$SOPH stock has now risen 7% today, according to our price data from Polygon. There has been approximately $1,181,816 of trading volume.

Here is what we see in our data on $SOPH (you can track the company live on Quiver's $SOPH stock page):

$SOPH Insider Trading Activity

SOPH Insider Trades

$SOPH insiders have traded $SOPH stock on the open market 103 times in the past 6 months. Of those trades, 1 have been purchases and 102 have been sales.

Here’s a breakdown of recent trading of $SOPH stock by insiders over the last 6 months:

  • JURGI CAMBLONG (Executive Chairman) has made 0 purchases and 24 sales selling 292,833 shares for an estimated $1,601,515.
  • PHILIPPE MENU (Chief Medical Officer) has made 0 purchases and 17 sales selling 53,773 shares for an estimated $266,300.
  • ZHENYU XU (Chief Scientific Officer) has made 0 purchases and 14 sales selling 35,773 shares for an estimated $176,957.
  • ROSS MUKEN (Chief Executive Officer) has made 0 purchases and 12 sales selling 33,653 shares for an estimated $166,215.
  • GEORGE CARDOZA (Chief Financial Officer) has made 1 purchase buying 20,000 shares for an estimated $99,000 and 6 sales selling 9,476 shares for an estimated $47,067.
  • MANUELA VALENTE (Chief People Officer) has made 0 purchases and 7 sales selling 14,178 shares for an estimated $69,664.
  • WELL DAAN VAN (Chief Legal Officer) has made 0 purchases and 8 sales selling 14,406 shares for an estimated $69,282.
  • ABHIMANYU VERMA (Chief Technology Officer) has made 0 purchases and 3 sales selling 8,834 shares for an estimated $44,213.
  • KATHY L HIBBS sold 7,508 shares for an estimated $35,036
  • KEVIN PUYLAERT (Chief Sales Officer) has made 0 purchases and 10 sales selling 942 shares for an estimated $4,607.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$SOPH Hedge Fund Activity

We have seen 27 institutional investors add shares of $SOPH stock to their portfolio, and 16 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

EARLY ACCESS
Receive SOPH Data Alerts
Real-time alerts on filings, insider trades, and market signals — before everyone else.
Get Alerts →

$SOPH Analyst Ratings

Wall Street analysts have issued reports on $SOPH in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • BTIG issued a "Buy" rating on 05/06/2026

To track analyst ratings and price targets for $SOPH, check out Quiver Quantitative's $SOPH forecast page.

$SOPH Price Targets

Multiple analysts have issued price targets for $SOPH recently. We have seen 2 analysts offer price targets for $SOPH in the last 6 months, with a median target of $7.5.

Here are some recent targets:

  • Mark Massaro from BTIG set a target price of $8.0 on 06/15/2026
  • Subbu Nambi from Guggenheim set a target price of $7.0 on 01/26/2026

You can track data on $SOPH on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

SOPHiA GENETICS SA (SOPH)